No abstract

Purpose: To know the level of awareness among women about cervical cancer and human papilloma virus (HPV) vaccines for its prevention. Method: Questionnaire-based observational study of 500 women. Results: Our study revealed that public awareness about cancer cervix in India is hardly 34% and that about HPV vacci nes and their role in preventing cancer cervix a meagre 12%. Conclusion: According to our study, only a minority of our women are aware about cancer cervix and hardly a handful know about HPV vaccines. By directing our efforts in further increasing this awareness and hopefully including these vaccines in immunization protocol, can we ever imagine fighting this gigantic problem in India?

Background: Abnormal uterine bleeding (AUB) is a common problem among women in the reproductive age group, with reported prevalence in India being 17.9%, AUB has a substantial effect on health-related quality of life and morbidity related if requiring surgeries. The objective of this study was to evaluate various histopathological features in endometrial curetting and co-relate them with transvaginal ultrasonographic findings.Methods: The study consisted of 500 cases who presented to the Department of Obstetrics and Gynaecology with complaints of abnormal uterine bleeding. Relevant history was elicited from all cases and a clinical examination was done. All cases underwent endometrial biopsy followed by transvaginal ultrasonography before surgery and the results were compared with the histopathological study of the specimen.Results: 16.7% of patients diagnosed with AUB had severe anemia requiring transfusion of blood. 4.2% of subjects in the study were nulliparous. 59.7% of subjects had an endometrial thickness ranging from 10mm to 14.9 mm in the transvaginal ultrasonographic study. Endometrial carcinoma accounted for 1.4% of the study population. Normal USG findings were seen in 18.1% of patients.Conclusions: In conclusion, a significant association was found between ultrasound and histopathological findings.

No abstract

Background: Pregnant women are more likely to suffer severe COVID-19 illness, during the second wave of the COVID-19 pandemic in India, there were increased pregnant cases of severe COVID-19. Following first wave due to the wild alpha variant, the vaccine efficacy was questioned during second wave caused by beta and omicron. When compared to receiving only two doses, a third dose (booster dose) that was given at least five months following the second dose significantly decreased the rate of COVID-19 symptoms and severe COVID-19 caused by all variants.Methods: A prospective hospital based cross-sectional study was undertaken at SSIMS AND RC, Davangere. This study was conducted on pregnant women visiting antenatal clinics and delivering at the department of OBG at S. S. hospital, Davangere.Results: The data was collected from Feb 2022 to April 2022 at our institute in women undergoing delivery with history of COVID 19 vaccination during pregnancy. A total of 188 cases were studied in the following duration, majority of the women belonged to the age group of 26 to 35 years. 54.8% of the cases were multiparous followed by 45.2% of the cases who were primigravida’s. The mean gestational age during admission and delivery of the patients involved in the study was 37.33 weeks, ranging from as early as 27 weeks of gestation to 40 weeks of gestation. There was no significant correlation between the neonatal and maternal complications seen in the study to the number of doses, gestational age and type of vaccine.Conclusions: Vaccinating everyone is the most effective method of battling the current COVID-19 outbreak. Despite the lack of sufficient clinical data on long-term side effects, the decline in the number of new cases, critically sick patients, and mortality in many nations suggests that vaccines will put an end to the pandemic.